Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07768254 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT07768254 · ClinicalTrials.gov record · last posted 2026-08-17

A Study to Evaluate the Safety, Tolerability, PK and Preliminary Efficacy of HX15001 Combined With Etrasimod in Moderate-severe Ulcerative Colitis

Name: A Study to Evaluate the Safety, Tolerability, PK and Preliminary Efficacy of HX15001 Combined With Etrasimod in Moderate-severe Ulcerative Colitis — clinical trial record (NCT07768254)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 1

SponsorHelixon Biotechnology (Suzhou) Co., Ltd

Started2026-09-09

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of HX15001 injection combined with Etrasimod tablets in participants with moderately to severely active ulcerative colitis (UC).

Trial Details

NCT Number	NCT07768254
Lead Sponsor	Helixon Biotechnology (Suzhou) Co., Ltd
Conditions	Colitis, Ulcerative
Enrollment	32 participants
Start Date	2026-09-09
Primary Completion	2028-04-15 (estimated)
Study Completion	2028-04-15 (estimated)
Updated on ClinicalTrials.gov	2026-08-17